NL-OMON36569已完成不适用
Response to angiotensin II in formerly preeclamptic women. RETAP study. - RETAP-study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Healthy females with history of normotensive pregnancy, with a range of one to five years after their pregnancy.
- •- Females with a history of severe preeclampsia, with a range of one to five years after their pregnancy
排除标准
- •Diabetes mellitus
- •Diabetes gravidarum
- •BMI >= 30
- •Oral contraceptive pill use which can*t be temporally stopped
- •Participants with renal diseases
- •Participants with cardiovascular diseases
- •Treatment with anti-hypertensive drug
- •Blood pressure: systolic > 150, diastolic > 100 mmHg
- •Pregnant or lactating women
- •Any surgical or medical condition that in the opinion of the investigator would jeopardize the evaluation of efficacy or safety
研究者
相似试验
尚未招募
不适用
Response to angiotensin II in formerly preeclamptic women. RETAP study.Formerly preeclamptic womenNL-OMON26813niversity Medical Center Groningen50
未知
4 期
Evaluation of the effect of Angiotensin ll receptor blocker for plaque vulnerability after percutaneous coronary intervention (PCI)Hypertension with coronary artery diseaseJPRN-UMIN000001720The University of Tokushima, Cardiovascular Medicine40
尚未招募
不适用
Predictive Value of the Angiotensin-II type 1 and Endothelin Receptor Autoantibodies on disease course in COVID-19pneumoniaNL-OMON49663Erasmus MC, Universitair Medisch Centrum Rotterdam320
已完成
不适用
Study on pleiotropic effects of angiotensin II- receptor blockers (ARB) in hypertensive obese patients.HypertensionJPRN-UMIN0000004693M STUDY GROUP150
已完成
不适用
A Randomized Study of Angiotensin II Type 1 Receptor Blocker vs Dihydropidine Ca Antagonist for Treatment of Paroxysmal Atrial Fibrillation in Patients with HypertensioAtrial Fibrillation with HypertensionJPRN-C000000427The J-RHYTHM II Investigators400